115 related articles for article (PubMed ID: 35727535)
1. The Medical Science Liaison Role in Spain: A Survey Capturing the Opinion of Medical Department Professionals.
Matesanz-Marín A; Del Castillo AG; Sastre V; García C
Ther Innov Regul Sci; 2022 Sep; 56(5):805-813. PubMed ID: 35727535
[TBL] [Abstract][Full Text] [Related]
2. The medical science liaison role in Spain: A nationwide survey.
Sastre V; Matesanz-Marín A; García C; González Del Castillo A
Perspect Clin Res; 2022; 13(1):48-53. PubMed ID: 35198429
[TBL] [Abstract][Full Text] [Related]
3. The Medical Science Liaison Role in Spain: Opinion of the Commercial Department Personnel.
García García C; Riosalido Montero M; Sastre V; González Del Castillo A; Matesanz Marín A
Ther Innov Regul Sci; 2023 Sep; 57(5):1030-1039. PubMed ID: 37286925
[TBL] [Abstract][Full Text] [Related]
4. The Medical Science Liaison Role in Spain: A Survey About the Opinion of HealthCare Professionals.
González Del Castillo A; García C; Matesanz-Marín A; Gómez-Sánchez MJ; Sastre V
Ther Innov Regul Sci; 2022 Jan; 56(1):96-103. PubMed ID: 34417761
[TBL] [Abstract][Full Text] [Related]
5. Proposal of Standard for Medical Science Liaison (MSL) Profession in Japan: A Viewpoint from the Japanese Association of Pharmaceutical Medicine (JAPhMed).
Tomiyasu M; Hayashi K; Moritsugu Y; Miyachi N; Iwamoto K; Nitta M; Mori M; Iwasaki K
Pharmaceut Med; 2020 Oct; 34(5):315-326. PubMed ID: 33030675
[TBL] [Abstract][Full Text] [Related]
6. A Survey of Key Opinion Leaders to Support Curriculum Development in Advanced Medical Science Liaison Training.
Moss RJ; Smith EB; Anderson G; Rozenfeld V; Evangelista C; Trahey C; Venuti C; Weiner EJ
Ther Innov Regul Sci; 2015 Jan; 49(1):45-49. PubMed ID: 30222457
[TBL] [Abstract][Full Text] [Related]
7. Evaluating Metrics Applied to the Medical Science Liaison (MSL) Role: A Survey-Based Study of Canadian MSL Leaders.
Saleem M; Cesario L; Wilcox L; Haynes M; Collin S; Langlois P; Kenyon S; Chilelli A
Ther Innov Regul Sci; 2021 Sep; 55(5):954-965. PubMed ID: 33945122
[TBL] [Abstract][Full Text] [Related]
8. Medical Science Liaisons (MSL) in Africa: a perspective.
Koot D; McMaster A; Nel M; van Tonder A; Barret A; Naidoo P
Pan Afr Med J; 2019; 33():313. PubMed ID: 31692862
[TBL] [Abstract][Full Text] [Related]
9. Health Care Professionals' Expectations of the Medical Science Liaison: A Blinded Survey.
Moss RJ; Black J
Ther Innov Regul Sci; 2013 Mar; 47(2):203-208. PubMed ID: 30227528
[TBL] [Abstract][Full Text] [Related]
10. Promoting Best Practices for Medical Science Liaisons Position Statement from the APPA, IFAPP, MAPS and MSLS.
Theron P; Britland M; Holder D; Ikeda Y; Rewers RF; Tiku A
Ther Innov Regul Sci; 2021 Nov; 55(6):1139-1144. PubMed ID: 34236693
[TBL] [Abstract][Full Text] [Related]
11. Survey on the Situation of Medical Departments in the Pharmaceutical Industry in Spain.
Sanchez-Magro I; Gomez-Lus S; Martínez-González J; Muñoz-Robles JA; Riesgo Y; Perez B; Hagen C; Viguera P
Pharmaceut Med; 2024 May; 38(3):241-250. PubMed ID: 38512636
[TBL] [Abstract][Full Text] [Related]
12. [What Is Medical Science Liaison?].
Sasaki M
Yakugaku Zasshi; 2019; 139(8):1093-1095. PubMed ID: 31366844
[TBL] [Abstract][Full Text] [Related]
13. An insight into the emerging role of regional medical advisor in the pharmaceutical industry.
Gupta SK; Nayak RP
Perspect Clin Res; 2013 Jul; 4(3):186-90. PubMed ID: 24010061
[TBL] [Abstract][Full Text] [Related]
14. Guidelines, editors, pharma and the biological paradigm shift.
Singh AR; Singh SA
Mens Sana Monogr; 2007 Jan; 5(1):27-30. PubMed ID: 22058616
[TBL] [Abstract][Full Text] [Related]
15. Criteria for site selection in industry-sponsored clinical trials: a survey among decision-makers in biopharmaceutical companies and clinical research organizations.
Dombernowsky T; Haedersdal M; Lassen U; Thomsen SF
Trials; 2019 Dec; 20(1):708. PubMed ID: 31829234
[TBL] [Abstract][Full Text] [Related]
16. Assessing stakeholder opinion on relations between cancer patient groups and pharmaceutical companies in Europe.
Leto di Priolo S; Fehervary A; Riggins P; Redmond K
Patient; 2012; 5(2):127-39. PubMed ID: 22299759
[TBL] [Abstract][Full Text] [Related]
17. Pharma Collaboration for Transparent Medical Information (phactMI) Benchmark Study: Trends, Drivers, Success Factors, and Value of Globalization in Medical Information.
Giffin SA; Shah R; Soloff A; Vaysman AM; Oreper J; Gažo A; Gandhi P; Shah I; Malieckal T; Boulos D; Flowers T; Stevens CA; Rocco MS; Patel AS; Albano D
Ther Innov Regul Sci; 2019 May; 53(3):332-339. PubMed ID: 29916261
[TBL] [Abstract][Full Text] [Related]
18. The Critical Need to Build a European Governance Model for Online Access to Medical Information Services: A Position Paper.
Pienaar S; Dunnett S; Flores A; Hamilton I; Mohamed S; De Wit J;
Pharmaceut Med; 2021 May; 35(3):147-155. PubMed ID: 34263444
[TBL] [Abstract][Full Text] [Related]
19. Awareness and enforcement of guidelines for publishing industry-sponsored medical research among publication professionals: the Global Publication Survey.
Wager E; Woolley K; Adshead V; Cairns A; Fullam J; Gonzalez J; Grant T; Tortell S
BMJ Open; 2014 Apr; 4(4):e004780. PubMed ID: 24747794
[TBL] [Abstract][Full Text] [Related]
20. phactMI Benchmarking Survey on Content Development and Inquiry Management.
Byun J; Jong JA; Gangat A; Flowers T; Gazo A; Shah I
Ther Innov Regul Sci; 2020 Nov; 54(6):1263-1268. PubMed ID: 33165760
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
